A resting electrocardiogram is a strange test to have opinions about. It is cheap, non-invasive, and takes five minutes, yet major guideline bodies including the U.S. Preventive Services Task Force explicitly recommend against routine EKG screening in asymptomatic adults at low cardiovascular risk. The reason is not that the test is bad. It is that in low-risk populations it changes management rarely and produces false alarms often.
The interesting question is not whether every adult should get an EKG but whether there is a case for a baseline tracing in your fifties, when the pretest probability of clinically relevant findings starts to climb and when a normal comparison strip can be genuinely useful later.
What the EKG actually shows
A twelve-lead EKG captures the heart's electrical activity from twelve angles over about ten seconds. It reliably identifies:
- Rhythm abnormalities, including atrial fibrillation, if present at the moment of recording.
- Conduction disease: bundle branch blocks, prolonged QT interval, atrioventricular block.
- Evidence of prior myocardial infarction, in the form of pathologic Q waves.
- Left ventricular hypertrophy, sometimes as a clue to hypertension or valve disease.
- A handful of inherited syndromes, such as long QT, Brugada, and Wolff-Parkinson-White.
What it does not show is coronary artery disease in its most common form: narrowed arteries in a symptom-free patient with normal function at rest. Screening for that requires different tools, and the guideline recommendation against routine EKGs largely reflects this mismatch.
The case for a baseline
There are three practical arguments for a single EKG in an otherwise well adult around age fifty.
First, atrial fibrillation becomes increasingly common with age and is often silent. Finding it changes stroke risk management substantially. A one-time EKG will not catch paroxysmal AF, but it is a starting point, and it primes the clinician to look for it.
Second, inherited conduction and repolarization disorders are uncommon but consequential. A prolonged QT interval, unrecognized, becomes a real problem when someone starts a new medication that further prolongs it. Knowing the baseline avoids that hazard.
Third, future comparisons are only as useful as the prior tracing. When a patient arrives in an emergency department with chest pain, a normal EKG from three years ago can materially change the interpretation of a subtly abnormal one today. The value of the baseline is not in what it finds but in what it enables later.
A baseline EKG is a hedge, not a screen. Its value shows up on the day something else goes wrong.
When more than a baseline is indicated
The guideline arguments against routine screening dissolve when symptoms or risk factors change the picture. Any of the following makes an EKG, and often more, appropriate:
- Palpitations, particularly sustained or associated with lightheadedness.
- Syncope or near-syncope.
- New or worsening exertional chest discomfort or dyspnea.
- A family history of sudden cardiac death, cardiomyopathy, or channelopathy before age fifty.
- Starting a medication known to prolong the QT interval, especially with other risk factors.
- Consideration of a new vigorous exercise program in someone previously sedentary with cardiovascular risk factors.
At higher intensity of concern, ambulatory monitoring, echocardiography, stress testing, or CT coronary angiography enter the conversation. The EKG is a starting point, not the final word.
Consumer devices and the incidental strip
Smartwatches and single-lead patches have made it common to arrive at an appointment with a recording of a suspicious rhythm. This is generally useful. A patient-captured AF episode that would otherwise have been missed can be the reason someone starts anticoagulation and avoids a stroke. It also generates noise: motion artifact, brief runs of ectopy, and low-quality tracings prompt visits that end without a diagnosis. Bring the strip, but hold conclusions until a twelve-lead confirms.
The bottom line
Guidelines are right that routine EKG screening in low-risk adults changes little. But a single well-timed baseline in your fifties is inexpensive, occasionally reveals something worth acting on, and quietly earns its keep the next time you land in a clinician's office with a symptom. Ask whether it makes sense for you, and keep a copy.